Nasal Spray Devices Market Share, Industry Analysis [2030]

Report Description

 Nasal Spray Devices Market Market Outlook:

The Global Nasal Spray Devices Market was estimated at USD 3,245.7 Million in 2021 and is anticipated to reach USD 6,044.1 Million by 2030, expanding at a CAGR of 6.9% during the forecast period.

Nasal spray devices are containers used to store the liquid and semi-solid formulations, which are available in unit/single dose, bi-unit, and multidose devices. These nasal spray devices come with portable packages for systemic and local administration, which allow easy and safe delivery of the nasal drug dosage.

These drug delivery devices are widely used for the topical treatment of local diseases in the nose and paranasal sinuses such as allergic, non-allergic rhinitis, and sinusitis. The closed container system used for nasal spray drug products includes pressurized metered devices and non-pressurized devices. The nasal spray devices are also used for delivering hormone treatments for mental illnesses through the nose.

Get Free Sample Report

Companies develop portable and safe nasal spray devices by adopting advanced technologies in their development process. For instance, AptarGroup, Inc. developed the CPS spray pump, which is a superior technology platform used in multi-dose nasal spray devices for precise and preservative-free nasal drug delivery in patients.

Nemera developed a ready-to-use primeless nasal device, which accurately delivers single-metered liquid doses for emergency lifesaving and crisis treatments. US Food and Drug Administration (FDA) offers regulatory guidelines for testing of physical properties of a nasal spray drug product, assessment of its accuracy, and dose uniformity of the nasal spray formulation.

Macro-economic Factors

R&D Investments

Research in the nasal spray devices market helps in the development of technologies for the treatment of various respiratory and infectious diseases, such as asthma, nasal congestion, and allergic rhinitis. Companies rely on R&D activities to plan, design, and deliver innovative technologies. For instance, Aptar Pharma Inc invested ~6% of its revenue in R&D spending. Thus, rising R&D programs are increasing the demand for nasal spray devices in the market.

Government Initiatives & Regulations

Government authorities issue various safety guidelines and regulations for the safety of citizens and healthcare workers. Various regulatory bodies streamline and set standards for various products in different countries across the globe.

Glenmark Pharmaceutical, in collaboration with SaNOtize research institute, introduced a nasal spray for the treatment of COVID-19. The Drug Controller General of India gave manufacturing and marketing approval for the Nitric Oxide Nasal Spray (NONS) for the treatment of COVID-19. Thus, rising support from government bodies is contributing to the growth of the nasal spray devices market.

Rising Respiratory Diseases

Respiratory diseases result in increasing health burdens across the globe. According to World Health Organization (WHO), more than 1 billion people suffer from respiratory conditions, and around 235 million people suffer from asthma globally. Thus, rising respiratory diseases is increasing the demand for nasal drug delivery system. Major market players in almost every industry rely on the development of nasal spray devices to improve the accuracy in nasal drug delivery process, thus boosting the use of nasal spray devices and other medical devices.

Market Dynamics

Market Driver- Increasing Awareness about Nasal Spray Devices

Nasal spray devices are largely used for the treatment of local diseases in a nasal passage. Several manufacturers of nasal spray devices use advertising campaigns to increase awareness about the benefits of nasal spray devices. Preference of patients for nasal spray devices is increasing, due to the growing awareness of efficacy and easy-to-administer properties of nasal spray devices, which is expected to fuel the market.

GSK group of companies, on May 10, 2022, introduced the “Life is a Struggle” campaign, which spread awareness for the treatment of blocked noses that ultimately increased the sale of nasal spray devices. Rising awareness among patients and physicians about the benefits of nasal spray drugs is expected to drive the market.

Market Driver- Rising Cases of Respiratory Diseases

Increasing pollution levels result in a massive increase in respiratory diseases across the globe. According to WHO, USD 4 million people die every year globally, due to outdoor air pollution that results in rising cases of respiratory diseases. Rising cases of respiratory diseases lead to a growing demand for nasal spray devices.

The use of nasal spray devices is increasing, due to their efficacy and easy-to-administer properties. For instance, Aptar Pharma Inc. manufactures preservative-free nasal spray devices based on PureHale technology for treating respiratory conditions. Increasing cases of patients with respiratory conditions such as allergic rhinitis, is expected to drive the market during the forecast period.

Market Restraint- Rising Complications Associated with the Overuse of Nasal Sprays

Nasal spray devices are easy to access, hence most people mistakenly presume that nasal sprays are safe and are unaware of the potential addiction or possible side effects. Rhinitis medicamentosa (RM) refers to the nasal inflammation caused by the excessive use of medications.

It has commonly occurred to patients who regularly use nasal spray devices without any medical advice or consultation from medical professionals, especially doctors. Continuous overuse of a nasal spray device leads to down-regulation of the receptors on the blood vessel in the nose.

It means that the capacity of receptors decreases and a rebound effect of nasal inflammation occurs when the user stops taking the drug. Atrophy of the nasal mucosa is a common drawback associated with rhinitis medicamentosa. Thus, a rising complication associated with the overuse of nasal spray drugs is projected to hinder the demand for nasal spray devices in the coming years.

Market Opportunity- Increasing R&D Activities

Major manufacturers of nasal spray devices are actively investing in the research & development (R&D) activities for the development of safe and high efficacy in the use of nasal drug delivery devices. Several innovative strategic approaches to design efficient nasal spray devices for effective nasal drug delivery system are key aspects of R&D activities.

Direct Haler A/S invested in the nasal drug delivery device used in the clinical trial development program. The device improves the efficacy in nasal drug delivery and increases patients’ acceptability. Companies in collaboration with regulatory bodies invest their resources in development of advanced nasal spray devices. These are key factors anticipated to provide lucrative opportunities for market players during the forecast period.

Scope of the Report  

The report on the global nasal spray devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Segmental Outlook

On the basis of dosage type, the global nasal spray devices market is segmented into unit/single dose, bi-dose, and multi-dose. The unit/single dose segment held a major market share in 2021 and is expected to expand at a CAGR of XX% from 2022 to 2030. A unit-dose device is a single-use, pre-filled, pre-assembled, and disposable product, such as IMITREX (sumatriptan nasal spray) and NARCAN (naloxone nasal spray). It is ideal for urgent treatments, which is driving the demand for unit/single-dose nasal sprays.

Get Free Sample Report

On the basis of container type, the global nasal spray devices market is bifurcated into non-pressurized containers and pressurized containers. The non-pressurized containers segment held a significant share of XX% in 2021 and is expected to expand at a CAGR of XX% from 2022 to 2030. These nasal sprays are convenient to use as compared to pressurized containers, which drives segment growth.

On the basis of application, the global nasal spray devices market is segmented into nasal congestion, allergic & non-allergic rhinitis, central nervous system disorders, vaccination, and others. The allergic & non-allergic rhinitis segment held a significant share of XX% in 2021 and is expected to expand at a CAGR of XX% from 2022 to 2030. It is considered to be one of the most prevalent chronic conditions.

Get Free Sample Report

Regional Outlook

On the basis of region, the global nasal spray devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for XX% of the market during 2021, due to the growing geriatric population and rising prevalence of allergic & non-allergic rhinitis diseases and CNS disorders. Increasing investments in technologically advanced medical devices and nasal sprays for efficient treatment are driving the market in North America.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-depth Analysis of the Global Nasal Spray Devices Market
• Historical, Current and Projected Market Size in Terms of Value
• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
• Industry Drivers, Restraints, and Opportunities Covered in the Study
• Recent Industry Trends and Developments
• Competitive Landscape & Strategies of Key Players
• Neutral Perspective on Global Nasal Spray Devices Market Performance